<p>(<b>A</b>) H/E (<b>a</b> and <b>e</b>) and esterase (<b>b</b> and <b>f</b>, arrows indicate cell infiltrates, asterisks indicate neuromuscular junctions) as well as EBD uptake (<b>c</b> and <b>g</b>) and eMyHC immunofluorescence (<b>d</b> and <b>h</b>, Hoechst was used to counterstain the nuclei) of TA cryosections derived from <i>mdx/θ<sup>−/−BMmdx/θ−/−</sup></i> (<b>a–d</b>) and from <i>mdx/θ<sup>−/−BMmdx</sup></i> (<b>e–h</b>) mice. Bar = 200 µm. (<b>B</b>) Extension of regenerating, eMyHC<sup>+ve</sup>, area and of necrotic, EBD<sup>+ve</sup>, area in <i>mdx/θ<sup>−/−BMmdx/θ−/−</sup></i> and in <i>mdx/θ<sup>−/−BMmdx</sup></i> expressed as the percentage in respect to the respective areas in <i>mdx</i> (assumed as 1), *<i>p<0.05</i>, ...
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by muscle wasting and chronic i...
<p>Three weeks after cell transplantation into MDX/SCID mice, many (β-gal/LacZ)+/dystrophin+ myofibe...
<p>(A) Shown is the treatment regimen with NBD mimetics in mdx mice. (B) Hematoxylin–eosin staining ...
<p>(<b>A</b>) eMyHC immunofluorescence (green) in TA cryosections derived from <i>mdx</i> (<b>a</b> ...
<p>(<b>A</b>) Hematoxylin/Eosin staining of TA crysosections derived from 2 mo old <i>mdx</i> (<b>a,...
<p>(<b>A</b>) PCR analysis of BM cell suspension genomic DNA derived from <i>mdx/θ<sup>−/−BMmdx/θ−/−...
<p>(<b>A</b>) Representative western blot analysis of total protein fraction of TA muscles derived f...
Our previous observations showed that lack of PKCθ in mdx, greatly improved muscle maintenance, rege...
<p>Left panel: representative Western Blot analysis of total protein fraction of TA muscles derived ...
<p>(A) Triple staining of <i>mdx</i> and <i>mdx52</i> mice for RF (green), eMHC (red), and nucleus (...
Inflammation is a key pathological characteristic of dystrophic muscle lesion formation, limiting mu...
<p><b>A</b>, expression of MHC molecules on wt (black lines) and IDE ko (grey lines) NOD splenocytes...
<p>(A-I) WT and ESAM-KO mice were treated with 150 mg/kg of 5-FU, and FACS analyses or methylcellulo...
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by muscle wasting and chronic i...
<p>(A) The C57BL/6JNarl mice were subjected to a lethal dose of 10 Gy γirradiation, and administered...
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by muscle wasting and chronic i...
<p>Three weeks after cell transplantation into MDX/SCID mice, many (β-gal/LacZ)+/dystrophin+ myofibe...
<p>(A) Shown is the treatment regimen with NBD mimetics in mdx mice. (B) Hematoxylin–eosin staining ...
<p>(<b>A</b>) eMyHC immunofluorescence (green) in TA cryosections derived from <i>mdx</i> (<b>a</b> ...
<p>(<b>A</b>) Hematoxylin/Eosin staining of TA crysosections derived from 2 mo old <i>mdx</i> (<b>a,...
<p>(<b>A</b>) PCR analysis of BM cell suspension genomic DNA derived from <i>mdx/θ<sup>−/−BMmdx/θ−/−...
<p>(<b>A</b>) Representative western blot analysis of total protein fraction of TA muscles derived f...
Our previous observations showed that lack of PKCθ in mdx, greatly improved muscle maintenance, rege...
<p>Left panel: representative Western Blot analysis of total protein fraction of TA muscles derived ...
<p>(A) Triple staining of <i>mdx</i> and <i>mdx52</i> mice for RF (green), eMHC (red), and nucleus (...
Inflammation is a key pathological characteristic of dystrophic muscle lesion formation, limiting mu...
<p><b>A</b>, expression of MHC molecules on wt (black lines) and IDE ko (grey lines) NOD splenocytes...
<p>(A-I) WT and ESAM-KO mice were treated with 150 mg/kg of 5-FU, and FACS analyses or methylcellulo...
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by muscle wasting and chronic i...
<p>(A) The C57BL/6JNarl mice were subjected to a lethal dose of 10 Gy γirradiation, and administered...
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by muscle wasting and chronic i...
<p>Three weeks after cell transplantation into MDX/SCID mice, many (β-gal/LacZ)+/dystrophin+ myofibe...
<p>(A) Shown is the treatment regimen with NBD mimetics in mdx mice. (B) Hematoxylin–eosin staining ...